TeamViewer shares plunge 19% after Q3 revenue fall, 2026 outlook cut

TeamViewer cut its 2026 constant-currency revenue growth forecast to -2% to -1% from 0% to 3% after Q3 revenue fell 3.9% to €184.5 million and ARR declined 2.6% to €736.9 million; shares fell 19% on Tuesday. Adjusted EBITDA dropped 10% to €78.9 million and margin narrowed to 42.8%, while net income rose 26% to €36 million and levered free cash flow increased 29%. Management cited slow enterprise deal conversions and low customer retention, but reaffirmed an adjusted EBITDA margin of around 43% and said it expects growth to accelerate in 2027 and beyond.

Analysis

The issue is less the revised growth range than the evidence that conversion and retention are weakening together. That raises the risk that slower European demand is exposing a product-distribution problem, not merely delaying purchases. Strong margins and cash generation cushion near-term financing risk, but they do not establish that the ARR base has stabilized; refinancing removes a liquidity overhang, not the need to restore organic growth.

Near term, the 19% drawdown may make an immediate short less attractive, while management’s 2027 confidence is not yet supported by measurable leading indicators. Over the next 1–3 months, watch ARR, retention, enterprise conversion and sales execution. The TeamViewer ONE adoption claim and AkzoNobel example are encouraging but company-selected evidence; neither demonstrates broad-based adoption or economics. If enterprise budgets remain delayed, Microsoft’s bundled endpoint/support tools and other DEX or remote-access providers may gain negotiating leverage, pressuring renewals and pricing. Over 6–18 months, sustained ARR contraction would likely shift the debate from cyclical recovery to weaker competitive positioning and constrain the growth multiple even if margins hold.

Contrarian angle: the cash-flow and margin profile may support a floor, and delayed U.S. public-sector deals could still convert. But treating those deals as deferred rather than lost requires evidence. Falsifiers are a return to positive ARR growth with improving retention and conversion, or, on the downside, further ARR deterioration and weaker margin/cash conversion.

Key Decisions for Investors

• Avoid buying the post-selloff solely on valuation: wait for the next update to show ARR stabilization and improving customer retention before adding exposure.
• For a tactical bearish expression, consider a defined-risk put spread or a relative-value short in TMV against a diversified software basket; stage entry after checking implied volatility and whether the shares fail to recover the post-results break. The 19% gap raises squeeze risk, so avoid an unhedged chase.
• Track enterprise pipeline conversion, net retention, new ARR, and sales productivity over the next 1–3 months. Treat the U.S. federal pipeline as upside optionality, not base-case recovery, until conversions are reported.
• Reassess the bearish thesis if ARR returns to growth and retention improves; strengthen it if another reporting period shows contraction alongside margin or levered free-cash-flow deterioration.